- Home
- CING vs LRE Comparison
CING vs LRE Comparison
Compare CING & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CING
- LRE
- Stock Information
- Founded
- CING 2012
- LRE 2001
- Country
- CING United States
- LRE Japan
- Employees
- CING N/A
- LRE N/A
- Industry
- CING Biotechnology: Pharmaceutical Preparations
- LRE
- Sector
- CING Health Care
- LRE
- Exchange
- CING Nasdaq
- LRE Nasdaq
- Market Cap
- CING 16.2M
- LRE 17.6M
- IPO Year
- CING 2021
- LRE 2023
- Fundamental
- Price
- CING $4.36
- LRE $2.00
- Analyst Decision
- CING Strong Buy
- LRE
- Analyst Count
- CING 4
- LRE 0
- Target Price
- CING $30.67
- LRE N/A
- AVG Volume (30 Days)
- CING 250.6K
- LRE 20.0K
- Earning Date
- CING 05-08-2025
- LRE 07-30-2015
- Dividend Yield
- CING N/A
- LRE N/A
- EPS Growth
- CING N/A
- LRE N/A
- EPS
- CING N/A
- LRE 0.29
- Revenue
- CING N/A
- LRE $117,804,154.00
- Revenue This Year
- CING N/A
- LRE N/A
- Revenue Next Year
- CING N/A
- LRE N/A
- P/E Ratio
- CING N/A
- LRE $6.62
- Revenue Growth
- CING N/A
- LRE 8.82
- 52 Week Low
- CING $1.80
- LRE $1.10
- 52 Week High
- CING $20.83
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- CING 61.94
- LRE 84.20
- Support Level
- CING $3.81
- LRE $1.86
- Resistance Level
- CING $4.09
- LRE $1.99
- Average True Range (ATR)
- CING 0.26
- LRE 0.12
- MACD
- CING 0.07
- LRE 0.06
- Stochastic Oscillator
- CING 96.43
- LRE 100.00
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.